SREBP1 and its encoding gene sterol regulatory element-binding transcription factor 1 (SREBF1) regulate lipid metabolic reprogramming, and their inhibition significantly induces GBM cell death [30,31,32,33], indicating that SREBP1 could be a promising target in GBM. Here, SREBF1 is linked to glioblastoma.